Cannula-based Versus Needle-based Subcision for Posttraumatic Atrophic Facial Scars
NCT ID: NCT05747898
Last Updated: 2023-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2021-11-01
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Subcision With PRP and Microneedling Versus Subcision With Saline and Micro-needling in Treatment of Posttraumatic Scars
NCT06135480
Autologous Plasma Gel Injection Versus Polydioxanone Cog Threads Insertion for the Treatment of Atrophic Post-acne Scars: a Split-face
NCT06580691
Subcision Followed by Diluted Calcium Hydroxylapatite Injection Versus Subcision Followed by Painting CROSS TCA Technique for the Treatment of Atrophic Acne Scars
NCT07028567
Nano Fat Injection With or Without Fractional Carbon Dioxide Laser in Acne Scars
NCT05985265
Carboxytherapy in the Treatment of Atrophic Scars
NCT05695807
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cannula arm
the cannula's 18 gauge tip was pointed upward and approximately parallel to the skin's surface when it was put into the superficial dermis, 1-2 millimeters away from the targeted scar. In order to completely remove fibrous tissue from the superficial dermis, a lancing motion (linear inserting-withdrawing needle action) was utilized first.
cannula- based subcision
Insertion of a needle into the base of a cutaneous scar to cut fibrous tissue and help new collagen formation.
Needle arm
The needle's 27 gauge tip was pointed upward and approximately parallel to the skin's surface when it was put into the superficial dermis, 1-2 millimeters away from the targeted scar. In order to completely remove fibrous tissue from the superficial dermis, a lancing motion (linear inserting-withdrawing needle action) was utilized first.
common- needle based subcision
Insertion of a cannula into the base of a cutaneous scar to cut fibrous tissue and help new collagen formation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cannula- based subcision
Insertion of a needle into the base of a cutaneous scar to cut fibrous tissue and help new collagen formation.
common- needle based subcision
Insertion of a cannula into the base of a cutaneous scar to cut fibrous tissue and help new collagen formation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mohamed
Lecturer of Dermatology, Venereology, and Andrology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marwa Mohamed, MD
Role: PRINCIPAL_INVESTIGATOR
Sohag University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University
Sohag, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
subatrophic001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.